Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization

Circulation

Volumn 95, Issue 8, 1997, Pages 2037-2043

  Davies, Richard F ^a   Goldberg, A David ^b   Forman, Sandra ^b   Pepine, Carl J ^b   Knatterud, Genell L ^b   Geller, Nancy ^b   Sopko, George ^b   Pratt, Craig ^b   Deanfield, John ^b   Conti, C Richard ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b NONE

Author keywords

coronary disease; drugs; electrocardiography; prognosis; revascularization; survival

Indexed keywords

ATENOLOL; DILTIAZEM; ISOSORBIDE DERIVATIVE; NIFEDIPINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030897113     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.8.2037     Document Type: Article

References (23)

1. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990;81:748-756.
2. Yeung AC, Barry J, Selwyn AP. Silent ischemia after myocardial infarction: prognosis, mechanism, and intervention. Circulation. 1990;82(suppl II):II-143-II-148.
3. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine CJ, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol. 1995; 26:594-605.
4. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, Pratt G, Stone PH, Davies RF, Rogers WJ, Deanfield JE, Goldberg AL, Ouyang P, Mueller H, Sharaf B, Day P, Selwyn AP, Conti CR, ACIP Investigators. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischemia pilot (ACIP) study. J Am Coll Cardiol. 1994;24:11-20.
5. Pepine CJ, Geller NL, Knatterud GL, Bourassa MG, Chaitman BR, Davies RF, Day P, Deanfield JE, Goldberg AD, McMahon RP, Mueller H, Ouyang P, Pratt C, Proschan M, Rogers WJ, Sharaf B, Sopko G, Stone PH, Conti CR, ACIP Investigators. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol. 1994;24:1-10.
6. Conti CR, Knatterud GL, Sopko G. Correction. J Am Coll Cardiol. 1995;26:842.
7. Coronary Artery Surgery Study (CASS) Principal Investigators and Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation. 1983;68:939-950.
8. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration Randomized Trial of Coronary Bypass Surgery for Stable Angina Pectoris. N Engl J Med. 1984;311:1333-1337.
9. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet. 1982;2:1173-1180.
10. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, Morris C, Mathur V, Vanauskas E, Chalmers TC. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570.
11. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA, Chaitman BR. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: long-term CASS experience. Circulation. 1995;91: 2335-2344.
12. Zack PM, Chaitman BR, Davis KB, Kaiser GC, Wiens RD, Ng G. Survival patterns in clinical and angiographic subsets of medically treated patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease (CASS). Am Heart J. 1989;118:220-227.
13. Killip T, Passamani E, Davis K. Coronary Artery Surgery Study (CASS): a randomized trial of coronary bypass surgery: eight years follow-up and survival in patients with reduced ejection fraction. Circulation. 1985;72(pt 2):V-102-V-109.
14. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665-1671.
15. American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. ACC/AHA guidelines and indications for coronary artery bypass graft surgery. Circulation. 1991;83:1125-1173.
16. Mulcahy D, Husain S, Zalos G, Rehman A, Andrews NP, Schenke WH, Geller NL, Quyyumi AA. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA. 1997;277:318-324.
17. Mahmarian JJ, Steingart RM, Forman S, Sharaf BL, Coglianese ME, Miller DD, Pepine CJ, Goldbert AD, Bloom MF, Byers S, Dvorak L, Pratt CM, for the Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators. Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. J Am Coll Cardiol. In press.
18. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U, ASIST Study Group. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the Atenolol Silent Ischemia Study (ASIST). Circulation. 1994;90:762-768.
19. Ruberman W, Crow R, Rosenberg CR, Rautaharju PM, Shore RE, Pasternack BS. Intermittent ST depression and mortality after myocardial infarction. Circulation. 1992;85:1440-1446.
20. Van Boven AJ, Jukema W, Zwinderman AH, Crijns HJGM, Lie KI, Bruschke AVG, REGRESS Study Group. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. Circulation. 1996;94:1503-1505.
21. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
22. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Chuan-Ghuan W, Davis BR, Braunwald E, CARE Investigators. The effect of prava-statin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335: 1001-1009.
23. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med. 1997; 336:153-162.